跳至主要内容
临床试验/NCT05389774
NCT05389774招募中不适用

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes

Nottingham University Hospitals NHS Trust10 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2023年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
10
主要终点
Determine the potential effect of the LCP on discharge

研究概览

简要总结

This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients are eligible for the study if all of the following apply:
  • Are aged 35 years or above
  • Have baseline CT study with at least one incidentally detected solid or part-solid (must have a solid component >=80%) pulmonary nodule that:
  • is not fully calcified
  • Is 5-30mm inclusive in maximum axial diameter for the whole lesion measured using manual electronic callipers
  • Have baseline CT study that includes at least one series that meets all of the following (training for this will be provided):
  • Is of a type that meets VNC instructions for use
  • Comprises at least one full-inspiration breath-hold scans without a high degree of contrast media and does not exhibit quality issues (e.g., motion artefacts)

排除标准

  • Patients will be excluded from the study if any of the following apply:
  • Have received a diagnosis for cancer in the last 5 years
  • Have thoracic implants that impact the image appearance of the nodule
  • Have more than five reported pulmonary nodules of any size or type excluding fully calcified nodules (this criterion is used as a proxy due to the risk of being an infection or metastasis)
  • Have one or more additional nodules where any of the following applies:
  • Are already undergoing follow-up according to pulmonary nodule management standard care
  • Pure ground glass opacity (GGO) of >=5mm in maximum axial diameter for the whole lesion measured using manual electronic callipers
  • >30mm in maximum axial diameter for the whole lesion measured using manual electronic callipers

结局指标

主要结局

Determine the potential effect of the LCP on discharge

时间窗: up to 1 year.

Measured difference between standard care, LCP and LCP-guided care for: * Percentage of cancer patients discharged (straight after assessment of the baseline scan) * Percentage of benign-nodule patients discharged (straight after assessment of the baseline scan)

次要结局

  • Determine the potential effect of the LCP on possible adherence to clinical guidelines.(up to 1 year.)
  • Determine the potential effect of the hypothetical LCP-informed care versus standard care on patient outcomes.(up to 1 year.)
  • Determine the potential effect of the LCP on overall clinical management, as well as scan and procedure utilization.(up to 1 year.)
  • Determine the potential health-economic effect of the hypothetical LCP-informed care versus standard care(up to 1 year.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验